Heghine Khachatryan on ITP’s Key Research Gaps: Biomarkers, Fatigue and Thrombosis Risk
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post by ITP Support Association on LinkedIn:
“One important research priority in ITP is understanding disease heterogeneity and treatment response.
Which immunological and clinical biomarkers can predict progression to chronic or refractory ITP and guide personalized therapy (steroids, TPO-RAs, rituximab, fostamatinib)?
In addition, fatigue remains a major unmet need in ITP and often persists despite adequate platelet counts. Understanding its inflammatory and immune mechanisms would have a major impact on patient quality of life.
Finally, the balance between bleeding and thrombosis risk in ITP—especially in patients treated with TPO-receptor agonists and during pregnancy—requires further real-world and prospective studies.”
Quoting ITP Support Association’s post:
“Got an idea for ITP research?
We’ve funded studies on fatigue, pregnancy, MRI, bone marrow, and more. Now we want YOUR input!
What should researchers explore next in ITP?
Drop your ideas in the comments below You can also email your ideas for research to [email protected] and we will collate all the responses from the comments and emails and discuss with our medical advisory team.”
Stay updated and find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque